about
Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis.Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort.Hierarchy of Impairment of Spinal Mobility Measures in Ankylosing Spondylitis: Twelve-Year Data.Epidemiology of spondyloarthritis.Lifestyle factors may modify the effect of disease activity on radiographic progression in patients with ankylosing spondylitis: a longitudinal analysisScoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?Prevalence of self-reported spondyloarthritis features in a cohort of patients with inflammatory bowel disease.Importance of Contextual Factors When Measuring Work Outcome in Ankylosing Spondylitis: A Systematic Review by the OMERACT Worker Productivity Group.Global Prevalence of Spondyloarthritis: A Systematic Review and Meta-Regression Analysis.Do extra-articular manifestations influence outcome in ankylosing spondylitis? 12-year results from OASIS.Gender-attributable differences in outcome of ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study.Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study.Neutral lateral fingertip-to-floor distance can be derived from height.Aspects of validity of the self-administered comorbidity questionnaire in patients with ankylosing spondylitis.Characteristics associated with the presence and development of extra-articular manifestations in ankylosing spondylitis: 12-year results from OASIS.Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study.Brief report: erosions and sclerosis on radiographs precede the subsequent development of syndesmophytes at the same site: a twelve-year prospective followup of patients with ankylosing spondylitis.
P50
Q31136770-72B6025C-81C0-4ABA-AEF6-C9B36248BB8FQ35165774-7A200249-8492-4A64-A418-0449F8296061Q35635197-98FA8438-B321-4FB2-86BF-C0B60D28CDA5Q35750729-3A14D103-DCD7-44E7-978C-6DB153DA7021Q36215822-1821C732-B302-413B-8E9B-5F504D2F5B18Q36903420-3B812CCC-DA1A-439B-B06E-8C81B696AC61Q37092635-804D9DDA-53A2-4508-84A8-DCA04789AA5FQ38366941-80F2BC46-96E9-43A5-9569-BC7031C09A38Q38682092-C55E2714-49CE-43D9-9DF7-10D4284B6153Q40025889-73704B2F-0109-4CFC-8BB6-606CF936A617Q40523969-2E228193-E990-4899-A177-611068F26BFAQ43927240-2C131BC5-41A3-43BA-9901-6090E6223F1AQ47579641-E6B354B0-51E5-4D2A-B43E-FD2BB4FB8A1BQ48132561-73939440-A8DA-4A9B-951D-317BE143E6A1Q49045624-65D08ACA-192D-4EAA-8EFA-4460BB584A93Q51104000-76382231-4AFE-4A71-9F46-DD50D625A2BDQ53086638-C237F3F8-332E-4BEF-ABC4-C1DED3A38CDC
P50
name
Carmen Stolwijk
@en
type
label
Carmen Stolwijk
@en
prefLabel
Carmen Stolwijk
@en